### Effects of rs34637584 in Cis-Acting Elements

#### 1. **Variant Identification**
   - **rs Number**: [rs34637584](https://identifiers.org/dbsnp/rs34637584)
   - **Gene Name**: *LRRK2* (Leucine-Rich Repeat Kinase 2)
   - **HGVS Notation**:
     - Genomic: `chr12:g.40340400G>A`
     - Transcript: `ENST00000298910.12:c.6055G>A`
     - Protein: `ENSP00000298910.7:p.Gly2019Ser`
   - **Transcript IDs**: Multiple transcripts are affected, including ENST00000298910, ENST00000680422, and others.

#### 2. **Cis-Acting Element Effects**
   - The variant rs34637584 is primarily known for its **missense mutation** effect, resulting in the substitution of glycine with serine at position 2019 in the *LRRK2* protein. However, its potential effects on **cis-acting elements** (e.g., regulatory regions like promoters, enhancers, or untranslated regions) are less well-documented.
   - Based on the retrieved data:
     - Some transcripts (e.g., ENST00000430804, ENST00000679360) show consequences in untranslated regions (UTRs), specifically in the **3' UTR**. Variants in UTRs can influence mRNA stability, localization, or translation efficiency, potentially affecting gene expression.
     - The specific consequences for cis-regulatory elements (e.g., enhancers or silencers) are not explicitly mentioned in the TogoVar data.

#### 3. **Disease Associations**
   - This variant is strongly associated with **Parkinson's disease (PD)**, particularly autosomal dominant forms (e.g., *Autosomal dominant Parkinson disease 8*). While the primary mechanism involves protein dysfunction, regulatory effects in cis-acting elements could modulate *LRRK2* expression and contribute to disease phenotypes.

#### 4. **Predictive Models**
   - **SIFT**: 0.0 (deleterious)
   - **PolyPhen**: 1.0 (probably damaging)
   - **AlphaMissense**: 0.936 (likely pathogenic)
   - These scores focus on protein-level effects but do not directly address cis-regulatory impacts.

#### 5. **Allele Frequency Comparison**
   - **Japanese Population**:
     - Tohoku Medical Megabank (ToMMo): Allele frequency = 0.000028
     - GEM-J WGA: Allele frequency = 0.0000659
   - **Non-Japanese Populations**:
     - gnomAD Exomes: Allele frequency = 0.000416
     - gnomAD Genomes: Allele frequency = 0.000361
   - The variant is rarer in Japanese populations compared to global datasets, suggesting potential population-specific regulatory effects.

#### 6. **GWAS Findings**
   - No direct GWAS findings link rs34637584 to cis-regulatory effects. However, its association with Parkinson's disease suggests it may influence gene expression or splicing in addition to its protein-coding impact.

#### 7. **TogoVar Link**
   - [TogoVar: rs34637584](https://togovar.org/variant/tgv45580587)

---

### Summary in Japanese
#### rs34637584のシス作用エレメントへの影響

1. **バリアントの特定**
   - **rs番号**: [rs34637584](https://identifiers.org/dbsnp/rs34637584)
   - **遺伝子名**: *LRRK2*（ロイシンリッチリピートキナーゼ2）
   - **HGVS表記**:
     - ゲノム: `chr12:g.40340400G>A`
     - トランスクリプト: `ENST00000298910.12:c.6055G>A`
     - タンパク質: `ENSP00000298910.7:p.Gly2019Ser`

2. **シス作用エレメントへの影響**
   - このバリアントは主に**ミスセンス変異**として知られていますが、**シス作用エレメント**（プロモーター、エンハンサー、UTRなど）への影響については十分に記載されていません。
   - データによると、一部のトランスクリプト（例: ENST00000430804, ENST00000679360）は**3' UTR**に影響を及ぼします。UTRの変異はmRNAの安定性、局在、翻訳効率に影響を与える可能性があります。

3. **疾患との関連**
   - このバリアントは**パーキンソン病（PD）**、特に常染色体優性型（例: *Autosomal dominant Parkinson disease 8*）と強く関連しています。

4. **予測モデル**
   - **SIFT**: 0.0（有害）
   - **PolyPhen**: 1.0（おそらく有害）
   - **AlphaMissense**: 0.936（病原性の可能性が高い）

5. **アレル頻度の比較**
   - **日本人集団**:
     - ToMMo: アレル頻度 = 0.000028
     - GEM-J WGA: アレル頻度 = 0.0000659
   - **非日本人集団**:
     - gnomAD Exomes: アレル頻度 = 0.000416
     - gnomAD Genomes: アレル頻度 = 0.000361

6. **GWASの発見**
   - rs34637584がシス調節効果に直接関連するGWASの結果はありません。

7. **TogoVarリンク**
   - [TogoVar: rs34637584](https://togovar.org/variant/tgv45580587)